Cargando…
Concordance Between Genomic Alterations Detected by Tumor and Germline Sequencing: Results from a Tertiary Care Academic Center Molecular Tumor Board
OBJECTIVE: The majority of tumor sequencing currently performed on cancer patients does not include a matched normal control, and in cases where germline testing is performed, it is usually run independently of tumor testing. The rates of concordance between variants identified via germline and tumo...
Autores principales: | Green, Michelle F, Watson, Catherine H, Tait, Sarah, He, Jie, Pavlick, Dean C, Frampton, Garrett, Riedel, Jinny, Plichta, Jennifer K, Armstrong, Andrew J, Previs, Rebecca A, Kauff, Noah, Strickler, John H, Datto, Michael B, Berchuck, Andrew, Menendez, Carolyn S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9847540/ https://www.ncbi.nlm.nih.gov/pubmed/35962742 http://dx.doi.org/10.1093/oncolo/oyac164 |
Ejemplares similares
-
Multicenter Comparison of Molecular Tumor Boards in The Netherlands: Definition, Composition, Methods, and Targeted Therapy Recommendations
por: Koopman, Bart, et al.
Publicado: (2020) -
Eccrine Carcinoma With an Unknown Primary: Managing Occult Cancer Through Multidisciplinary Tumor Board Collaboration
por: Mariano, Melissa, et al.
Publicado: (2022) -
Concordance of Solid Organ Biopsy Diagnoses With Hospital Autopsy and the Contribution of Biopsies to Death
por: Priemer, David S, et al.
Publicado: (2023) -
Validation of a Circulating Tumor DNA‐Based Next‐Generation Sequencing Assay in a Cohort of Patients with Solid tumors: A Proposed Solution for Decentralized Plasma Testing
por: Al Zoughbi, Wael, et al.
Publicado: (2021) -
Discordance in Tumor Mutation Burden from Blood and Tissue Affects Association with Response to Immune Checkpoint Inhibition in Real-World Settings
por: Sturgill, Emma G, et al.
Publicado: (2022)